In recent years, Zhongshan City has issued and revised relevant policies to increase support and help a number of local enterprises to be listed on the stock market at home and abroad.

Despite COVID-19, two Zhongshan-based enterprises were successfully listed in Hong Kong so far this year.

SANVO Fine Chemicals Group Limited was listed on the HK main board of the Hong Kong stock exchanges. Founded in 2002, SANVO is an experienced manufacturer of fine chemical products in China. The compay owns Guangdong Sanvo Chemical Technology Co Ltd and Guangdong Sanvo Holding Co Ltd in Huangpu Town, Zhongshan City.

Akeso Biopharma Inc was listed on the Hong Kong stock exchanges. It is a scientific innovation enterprise that developed in Zhongshan. For the past 8 years, Akeso Biopharma Inc has taken Zhongshan as its R&D headquarters and has subsidiaries in the United States, Australia, Beijing, Shanghai and Guangzhou. Its management team consists of immunologists and experts in antibody drug R&D and GMP production, who have worked for many years in world-renowned pharmaceutical enterprises.

As of now, 34 Zhongshan-based companies are listed on the domestic and overseas markets, and 55 are listed on the NEEQ market. In the first half of the year, Zhongshan's new direct financing totaled 3.523 billion yuan.